Nadia Eltaki, MD

Dr. Berman is an anesthesiologist specializing in high-risk obstetric anesthesiology, anesthesia for fetal surgery, general adult anesthesiology, and medical education. Additionally, he serves as assistant program director of the anesthesiology residency program at Johns Hopkins.He attended medical school at the Icahn School of Medicine at Mount Sinai and elected to remain at Mount Sinai for his anesthesiology residency. During medical school, he was awarded the Jagust award for highest-performing medical student in anesthesiology and went on to be selected by his peers for induction in the Gold Humanism Honor Society. He was a member of the Eliasberg Research Program and the clinician-educator track as a resident.He then completed a fellowship in obstetric, gynecologic and fetal anesthesia at Johns Hopkins, where he received numerous clinical and teaching awards. He subsequently joined the Department of Anesthesiology and Critical Care Medicine as full-time faculty.Since joining ACCM, Dr. Berman has been appointed assistant program director of the anesthesiology residency and received the Rising Faculty Award, the Beattie Teacher of the Year Award several times, and the Most Innovative Faculty award. He was also awarded the Society for Obstetric Anesthesia and Perinatology Teacher of the Year Award. He is a core member of the hepatobiliary anesthesia team, performing complex hepatobiliary procedures on a regular basis. He also serves as a phone consultant for the Malignant Hyperthermia Hotline.Dr. Berman has a special interest in cardiac disease in pregnancy and the use of peripartum and perioperative echocardiography. He serves on a variety of national and international committees In the anesthesiology community. He is currently pursuing an MEHP from the Johns Hopkins School of Education. His research interests include personal financial literacy among physicians, curriculum design/development and medical student & resident education.

Matthew Ladra, M.D., M.P.H., leads the dedicated pediatric team for the Johns Hopkins Proton Therapy Center and is the director of pediatric radiation oncology for the Johns Hopkins Kimmel Cancer Center, a clinical collaboration with Children’s National Hospital, where Dr. Ladra serves as faculty in the department of pediatric oncology. He is also an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins School of Medicine. Listen Dr. Ladra's Cancer Matters podcast episode to learn more about his work.Previously, Dr. Ladra served as the director of pediatric radiation at the Provision Center for Proton Therapy in Tennessee. He also completed a 2-year fellowship in pediatric proton therapy at the Massachusetts General Hospital’s Francis H. Burr Proton Center. Dr. Ladra is one of a handful of radiation oncologists whose research and clinical efforts focus exclusively on pediatric patients. He is frequently invited to speak on pediatric radiation oncology topics internationally and across the U.S. and has published extensively on the subject through original research book chapters and review articles. Dr. Ladra’s research efforts focus mainly on pediatric rhabdomyosarcoma treatment, early phase clinical trials involving radiation and non-chemotherapeutic agents, and reducing neurocognitive toxicity for pediatric brain tumor patients.

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida.